Pediatric Cancers

Latest News

CHMP Recommends Mirdametinib for EU Approval in Adult/Pediatric NF1-PN
CHMP Recommends Mirdametinib for EU Approval in Adult/Pediatric NF1-PN

May 23rd 2025

The EMA’s CHMP has adopted a positive opinion for mirdametinib in patients with inoperable plexiform neurofibromas of neurofibromatosis type 1.

FDA Grants RMAT Designation to CAR T Therapy for Incurable Pediatric Glioma
FDA Grants RMAT Designation to CAR T Therapy for Incurable Pediatric Glioma

May 16th 2025

Prophylactic defibrotide conferred more ICU admissions and higher mortality among high-risk pediatric patients who underwent prior HSCT.
Post-HSCT Defibrotide Does Not Reduce Sinusoidal Obstruction Syndrome

February 14th 2025

Data from the phase 3 MSB-GVHD001 trial support the FDA approval of remestemcel-L in pediatric SR-aGVHD.
FDA Approves Remestemcel-L in Pediatric SR-aGVHD

December 18th 2024

The expanded approval of methotrexate may offer a convenient alternative to pediatric patients who have difficulty swallowing pills.
FDA Expands Approval for Methotrexate in Pediatric ALL, pJIA Indications

October 29th 2024

Video Interviews

More News